| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 8-K | Report | Data | 8-K | May 31, 2024 | May 30, 2024 |
| 10-Q | Report | Data | 10-Q | May 8, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | May 8, 2024 | May 8, 2024 |
| 8-K | Report | Data | 8-K | Apr 2, 2024 | Apr 2, 2024 |
| 10-K | Report | Data | 10-K | Feb 27, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | 8-K | Feb 27, 2024 | Feb 27, 2024 |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 13, 2024 | |
| SC 13G | Report | Jan 29, 2024 | ||
| SC 13G/A | Report | SC 13G/A | Jan 29, 2024 | |
| SC 13G/A | Report | Jan 23, 2024 | ||
| SC 13G/A | Report | SC 13G/A | Dec 11, 2023 | |
| SC 13G/A | Report | Dec 11, 2023 | ||
| 8-K | Report | Data | 8-K | Nov 29, 2023 | Nov 28, 2023 |
| 8-K | Report | Data | 8-K | Nov 13, 2023 | Nov 12, 2023 |
| 10-Q | Report | Data | 10-Q | Nov 7, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | 8-K | Nov 7, 2023 | Nov 7, 2023 |
| 8-K | Report | Data | 8-K | Oct 23, 2023 | Oct 23, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Aug 10, 2023 | Aug 10, 2023 |
| 8-K | Report | Data | 8-K | Jun 16, 2023 | Jun 15, 2023 |
| 8-K | Report | Data | 8-K | Jun 15, 2023 | Jun 14, 2023 |
| 10-Q | Report | Data | 10-Q | May 15, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | 8-K | May 15, 2023 | May 15, 2023 |
| 10-K | Report | Data | 10-K | Mar 2, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | 8-K | Mar 2, 2023 | Mar 2, 2023 |
| 8-K | Report | Data | 8-K | Feb 17, 2023 | Feb 14, 2023 |
| SC 13G/A | Report | 2023 FORM SC 13G/A | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | ARCH VENTURE FUND X, L.P. - VERVE THERAPEUTICS, INC. -- SCH 13G/A(#1E) | Feb 13, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2023 | |
| SC 13G | Report | Feb 10, 2023 | ||
| SC 13G | Report | SC 13G | Feb 10, 2023 | |
| SC 13G/A | Report | Feb 9, 2023 | ||
| SC 13G | Report | SCHEDULE 13G | Feb 9, 2023 | |
| SC 13G | Report | Feb 7, 2023 | ||
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 6, 2023 | |
| 8-K | Report | Data | 8-K | Dec 5, 2022 | Dec 2, 2022 |
| 10-Q | Report | Data | 10-Q | Nov 7, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | 8-K | Nov 7, 2022 | Nov 7, 2022 |
| SC 13G/A | Report | Aug 10, 2022 | ||
| 10-Q | Report | Data | 10-Q | Aug 9, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | 8-K | Aug 9, 2022 | Aug 3, 2022 |
| 8-K | Report | Data | 8-K | Jul 21, 2022 | Jul 20, 2022 |
| 8-K | Report | Data | 8-K | Jul 21, 2022 | Jul 20, 2022 |
| 8-K | Report | Data | 8-K | Jul 20, 2022 | Jul 18, 2022 |
| 8-K | Report | Data | 8-K | Jul 12, 2022 | Jul 12, 2022 |
| 8-K | Report | Data | 8-K | Jul 7, 2022 | Jul 5, 2022 |
| 8-K | Report | Data | 8-K | Jun 13, 2022 | Jun 9, 2022 |
| 10-Q | Report | Data | 10-Q | May 10, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | 8-K | May 10, 2022 | May 10, 2022 |
| 10-K | Report | Data | 10-K | Mar 14, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | 8-K | Mar 14, 2022 | Mar 14, 2022 |
| SC 13G | Report | SC 13G | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G | Report | ARCH VENTURE FUND X, L.P. - VERVE THERAPEUTICS, INC. -- SCH 13G | Feb 9, 2022 | |
| SC 13G/A | Report | Feb 9, 2022 | ||
| SC 13G | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
| SC 13G | Report | Jan 24, 2022 | ||
| SC 13G/A | Report | 13G/A | Dec 28, 2021 | |
| 8-K | Report | Data | 8-K | Nov 29, 2021 | Nov 24, 2021 |
| 10-Q | Report | Data | 10-Q | Nov 10, 2021 | Sep 30, 2021 |
| 8-K | Report | Data | 8-K | Nov 10, 2021 | Nov 10, 2021 |
| 8-K | Report | Data | 8-K | Aug 24, 2021 | Aug 19, 2021 |
| 10-Q/A | Report | Data | 10-Q/A | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Report | 10-Q | Aug 12, 2021 | Jun 30, 2021 |
| 8-K | Report | 8-K | Aug 12, 2021 | Aug 12, 2021 |
| SC 13G | Report | SEC SCHEDULE 13G | Jun 28, 2021 | |
| SC 13G | Report | Jun 23, 2021 | ||
| SC 13G | Report | Jun 23, 2021 | ||
| 8-K | Report | 8-K | Jun 21, 2021 | Jun 21, 2021 |